|
|
|
|
| LEADER |
00698cam#a2200241#a#4500 |
| 001 |
OMD010958 |
| 003 |
OMD |
| 005 |
20220829 185701 |
| 008 |
ns.f. xx a ||f |||| ||spa d |
| 022 |
# |
# |
|a 1234-56778
|
| 040 |
# |
# |
|a OMD
|b spa
|
| 060 |
# |
4 |
|a QU
|b 95
|
| 092 |
# |
# |
|c QU 95
|l LAB
|
| 110 |
2 |
# |
|a Laboratorios Parke-Davis.
|
| 245 |
1 |
0 |
|a Avances en dislipidemias /
|c Laboratorios Parke-Davis.
|
| 260 |
# |
# |
|a [s.l.] :
|b Laboratorio Parke-Davis,
|c [s.f.]
|
| 300 |
# |
# |
|a 10 volúmenes :
|b ilustraciones
|
| 336 |
# |
# |
|a texto
|b txt
|2 rdacontent
|
| 337 |
# |
# |
|a no mediado
|b n
|2 rdamedia
|
| 338 |
# |
# |
|a volumen
|b nc
|2 rdacarrier
|
| 650 |
# |
7 |
|a Dislipidemias
|2 Decs
|
| 650 |
# |
7 |
|2 Decs
|a Colesterol
|
| 650 |
# |
7 |
|2 Decs
|a Lipoproteínas
|
